Hepatitis B immunoglobulin (Xinjiang Deyuan Biological Engineering)

乙型肝炎人免疫球蛋白（新疆德源生物工程）

Report date: 2022/08/01 15:02:37

Base Information

Drug NameHepatitis B immunoglobulin (Xinjiang Deyuan Biological Engineering)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2022/07/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXinjiang Deyuan Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXinjiang Deyuan Biological Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A